Showing results (181-190 of 189) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 189 results.
Annals of the Rheumatic Diseases|November 23, 2014
Development of patient-centred standards of care for osteoarthritis in Europe: the eumusc.net-projectMichaela A Stoffer, Josef S Smolen, Anthony Woolf, et al.
Annals of the Rheumatic Diseases|April 26, 2022
2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseasesAnnette de Thurah, Philipp Bosch, Andrea Marques, et al.
Annals of the Rheumatic Diseases|June 9, 2023
EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritisAlen Zabotti, Gabriele De Marco, Laure Gossec, et al.
Annals of the Rheumatic Diseases|May 31, 2024
2023 EULAR classification criteria for hand osteoarthritisIda K Haugen, David T Felson, Abhishek Abhishek, et al.
RMD Open|February 5, 2022
Development of radiographic classification criteria for hand osteoarthritis: a methodological report (Phase 2)Ida K Haugen, David Felson, Abhishek Abhishek, et al.
RMD Open|May 25, 2023
Educational readiness among health professionals in rheumatology: low awareness of EULAR offerings and unfamiliarity with the course content as major barriers-results of a EULAR-funded European surveyValentin Ritschl, Lisa Sperl, Margaret Renn Andrews, et al.
Annals of the Rheumatic Diseases|August 11, 2022
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an updateDaniel Aletaha, Andreas Kerschbaumer, Kastriot Kastrati, et al.
Annals of the Rheumatic Diseases|September 3, 2020
EULAR/eumusc.net standards of care for rheumatoid arthritis: cross-sectional analyses of importance, level of implementation and care gaps experienced by patients and rheumatologists across 35 European countriesRachelle Meisters, Polina Putrik, Sofia Ramiro, et al.
Annals of the Rheumatic Diseases|November 10, 2022
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 updateJosef S Smolen, Robert B M Landewé, Sytske Anne Bergstra, et al.
Pageof 19